A study from our group in AML patients demonstrated ILC depletion by pre-transplantation conditioning radio- and chemotherapy and variable ILC reconstitution post-transplantation, irrespective of the preparative chemotherapy regimen intensity (i.e. myeloablative or non-myeloablative) (14). The gene discussed is CCL27; the disease is acute myeloid leukemia.